Back
ESC Premium Access

Albuminuria as a predictor of incident ischemic stroke and myocardial infarction in patients with type 2 diabetes but without cardiovascular disease: A Danish cohort study

Session: The right glucose-lowering drugs for the right patient
Topic: Cardiovascular Risk Assessment
Speaker: Mrs M. Fangel (Aalborg, DK)
Event: ESC Congress 2019

Congress Presentation

About the speaker

Mrs Mia Vicki Fangel

Aalborg University Hospital, Aalborg (Denmark)
0 follower

3 more presentations in this session

State of the Art in antidiabetic treatment to prevent CVD

Speaker: Professor A. Norhammar (Stockholm, SE)

Access
Slides
Video
Thumbnail

Cardiovascular risk profiles and outcomes in patients with type 2 diabetes - Implications for choice of new diabetes therapies

Speaker: Mrs M. Malik (Copenhagen, DK)

Access
Abstract
Slides
Video
Thumbnail

Heart failure risk stratification and efficacy of dapagliflozin in patients with type 2 diabetes mellitus

Speaker: Doctor D. Berg (Boston, US)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

The right glucose-lowering drugs for the right patient

Speakers: Mrs M. Fangel, Professor A. Norhammar, Mrs M. Malik, Doctor D. Berg
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb